EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial

Myungjin Kim, Chang-Kyu Lee iD, Jonghoon Shin iD, Doah Kim, Seungsoo Rho

Journal of Clinical Medicine · 26.02.2025 · 14 (5) · 1587

DOI: 10.3390/jcm14051587 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.02.2025. Verfasst von Myungjin Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hanlim Pharm (South Korea), Hanlim Pharm, Seoul, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objectives of the study were to compare the efficacy and safety using ocular surface assessment between preserved and preservative-free brimonidine/timolol fixed-combination eye drops in glaucoma or ocular hypertension patients.

Methods

This study was designed as a prospective, multicenter (three institutions), investigator-masked, parallel-grouped randomized clinical trial. The primary outcomes were corneal and conjunctival staining score, ocular surface disease index (OSDI) score, drug tolerance, and adherence rates at 12-week visits. The secondary outcomes were corneal and conjunctival staining score, OSDI score at 4-week visits and intraocular pressure (IOP), tear-film break-up time (TBUT), and bulbar/limbal hyperemia score at the 4- and 12-week visits. For safety assessment, best-corrected visual acuity (BCVA), systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), and physical examination at 4 and 12 weeks and adverse events during the whole study period were analyzed.

Results

Overall, 59 patients were enrolled and randomized into each group (29 preserved and 30 preservative-free). At the endpoint, 5 patients in the preserved group and 2 patients in the preservative-free group dropped out, leaving 24 and 28 patients in the preserved and preservative-free groups, respectively. Baseline characteristics showed no significant difference between the groups including age and sex. At the 12-week visit, intra-group change of OSDI scores did not change significantly compared to the baseline scores in both preserved and preservative-free groups (p = 0.791, 0.478, respectively). On the contrary, the corneal staining score and the conjunctival staining score showed a significant increase compared to the baseline score in the preserved group (p = 0.015, 0.009, respectively). Regarding drug satisfaction, higher proportions of patients in the preservative-free group reported convenience of installation (p = 0.002). Also, stinging and burning sensations in drug tolerance showed better results in the preservative-free group with a significant difference (p = 0.011). Safety assessment regarding systemic side effects such as SBP, DBP, and HR showed similar results between the preserved and preservative-free groups (p = 0.711, 0.232, 0.666, respectively).

Conclusions

Preservative-free brimonidine/timolol showed comparable efficacy and safety, better corneal and conjunctival staining score with convenience of installation, and lower stinging and burning sensation. It is expected to be a proper treatment option for patients with glaucoma or ocular hypertension.

Schlagwörter

Stichwörter der Autor:innen

adherencebrimonidine/timololconjunctival staining scorecorneal staining scoredrug toleranceefficacyglaucomaocular hypertensionocular surface disease indexpreservative-freesafety

Autor:innen und Institutionen

  • Department of Ophthalmology, CHA Bundang Medical Center, CHA University, Seongnam 13496, Republic of Korea.
  • Department of Ophthalmology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Republic of Korea.
  • Department of Ophthalmology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan 50612, Republic of Korea.
  • Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan 50612, Republic of Korea.
  • PNU Busan Eye Clinic, Busan 46241, Republic of Korea.

ORCID-Profile: Chang-Kyu Lee, Jonghoon Shin

Förderung

  • Hanlim Pharm (South Korea)
  • Hanlim Pharm, Seoul, Republic of Korea

Zitieren

APA

Kim, M., Lee, C. K., Shin, J., Kim, D., & Rho, S. (2025). Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial. Journal of Clinical Medicine, 14(5), 1587. https://doi.org/10.3390/jcm14051587

Vancouver

Kim M, Lee CK, Shin J, Kim D, Rho S. Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial. Journal of Clinical Medicine. 2025;14(5):1587. doi:10.3390/jcm14051587

BibTeX
@article{Kim2025,
  author = {Kim, Myungjin and Lee, Chang-Kyu and Shin, Jonghoon and Kim, Doah and Rho, Seungsoo},
  title = {Comparison of Efficacy and Ocular Surface Assessment Between Preserved and Preservative-Free Brimonidine/Timolol Fixed-Combination Eye Drops in Glaucoma Patients: A Parallel-Grouped, Randomized Trial},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {5},
  pages = {1587},
  doi = {10.3390/jcm14051587}
}
Kostenlos starten →